Organizations
Conferences
Info & Opinion
December 3, 2008
Revenues are up, but etrials says it is reorganizing its strategy, with new sales staff and attention to service.
Is it finally OK to say that the pharmaceutical industry’s dependence on paper is embarrassing?
“It’s a ride, ride, ride, and there ain’t much cover.” That Bruce Springsteen lyric came to mind as we were listening to the etrials call with financial analysts last week. On the face of it, it should have been a…
In the animal kingdom, the vivid plumage of a tropical bird is (for other birds) a reliable indicator of the creature’s health and reproductive vitality. Likewise, the size and splendor of a trade show exhibitor’s booth is an indicator of…
GlaxoSmithKline took a bullet from the anti-industry New England Journal of Medicine, which did a meta-analysis of data about the GSK diabetes drug Avandia. The Cleveland Clinic’s Steve Nissen calculates Avandia to raise the odds of cardiovascular-related death by 64…
Velos, a leader in clinical trial management information systems for large investigator sites, recently announced the release of Velos eResearch Version 7, bringing a host of advanced features and functions to its customers. The company’s news release said: “With Version…